D2 autoreceptors are not involved in the down-regulation of the striatal dopamine transporter caused by α-methyl-p-tyrosine

Research Communications in Molecular Pathology and Pharmacology

Volumn 104, Issue 3, 1999, Pages 331-338

  Han, Sue ^a   Rowell, Peter P ^a   Carr, Laurence A ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTORECEPTOR; DEXAMPHETAMINE; DOPAMINE; DOPAMINE 2 RECEPTOR; MAZINDOL; METIROSINE; QUINPIROLE; CARRIER PROTEIN; DOPAMINE TRANSPORTER; DOPAMINE UPTAKE INHIBITOR; MEMBRANE PROTEIN; NERVE PROTEIN; SLC6A3 PROTEIN, RAT;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINE METABOLISM; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; DOWN REGULATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; REGULATORY MECHANISM; STRIATE CORTEX; ANIMAL; CORPUS STRIATUM; DRUG EFFECT; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ALPHA-METHYLTYROSINE; ANIMALS; AUTORECEPTORS; CARRIER PROTEINS; CORPUS STRIATUM; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; DOWN-REGULATION; MALE; MAZINDOL; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2;

EID: 0033233293     PISSN: 10780297     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Borowsky, B. and Hoffman, B.J. (1995). Neurotransmitter transporters: molecular biology, function, and regulation. Int. Rev. Neurobiol. 38: 139-199.
2. Carr, L.A. and Rowell, P.P. (1990). Attenuation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity by tobacco smoke. Neuropharmacology 29: 311-314.
3. 2 dopamine receptors can modulate dopamine uptake. Neurosci. Lett. 176: 259-263.
4. Dickinson, S.D., Sabeti, J., Larson, G.A., Giardina, K., Rubinstein, M., Kelly, M.A., Grandy, D.K., Low, M., Gerhardt, G.A. and Zahniser, N.R. (1999). Dopamine D-2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum. J. Neurochem. 72: 148-156.
5. Eilam, D., Talangbayan, H., Canaran, G., Dai, H. and Szechtman, H. (1994). Behavioral sensitization induced by dopamine agonist quinpirole: dynamics, properties, and a proposed central energy control mechanism. Psychopharmacology 115: 95-104.
6. Eshleman, A.J., Henningsen, R.A., Neve, K.A. and Janowsky, A. (1994). Release of dopamine via the human transporter. Mol. Pharmacol. 45: 312-316.
7. Giros, B., Jaber, M., Jones, S.R., Wrightman, R.M. and Caron, M.G. (1996). Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379: 606-612.
8. Gordon, I., Weizman, R. and Rehavi, M. (1996). Modulatory effect of agents active in the presynaptic dopaminergic system on the striatal dopamine transporter. Eur. J. Pharmacol. 298: 27-30.
9. 3H]mazindol binding sites in rat striatum by dopaminergic agents. Eur. J. Pharmacol. 250: 261-266.
10. Iravani, M. and Kruk, Z.L. (1995). Effects of AMPH on carrier-mediated and electrically stimulated DA release in slices of rat caudate putamen and nucleus accumbens. J. Neurochem. 64: 1161-1168.
11. 3H]Mazindol binding associated with neuronal dopamine and norepinephrine uptake sites. Mol. Pharmacol. 26: 35-44.
12. Jones, S.R., Gainetdinov, R.R., Wightman, R.M. and Caron, M.G. (1998). Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J. Neuroscience 18: 1979-1986.
13. 2 receptors may modulate the function of the striatal transporter for dopamine: kinetic evidence from studies in vitro and in vivo. J. Neurochem. 61: 764-767.
14. Missale, C., Castelletti, L., Govoni, S., Spano, P.F., Trabucchi, M. and Hanbauer, I. (1985). Dopamine uptake is differentially regulated in rat striatum and nucleus accumbens. J. Neurochem. 45: 51-56.
15. Raiteri, M., Cerrito, F., Cervoni, A.M., del Carmine, R., Ribera, A.T. and Levi, G. (1978). Studies on dopamine uptake and release in synaptosomes. Adv. Biochem. Psychopharmacol. 19: 35-56.
16. Rivest, R., Falardeau, P. and Di Paolo, T. (1995). Brain dopamine transporter: gender difference and effect of chronic haloperidol. Brain Res. 692: 269-272.
17. Rowell, P.P. and Duggan, D. S. (1998). Long-lasting inactivation of nicotinic receptor function in vitro by treatment with high concentrations of nicotine. Neuropharmacology 37: 103-111.
18. Sullivan, R.M., Talangbayan, H., Einat, H. and Szechtman, H. (1998). Effects of quinpirole on central dopamine systems in sensitized and non-sensitized rats. Neuroscience 83: 781-789.
19. 2 receptors by chronic haloperidol, nitrendipine, and pimozide. Biol. Psychiat. 21: 1114-1122.
20. Walters, D.E. and Carr, L.A. (1988). Perinatal exposure to cannabinoids alters neurochemical development in rat brain. Pharmacol. Biochem. Behav. 29: 213-216.